Skip to content
Lower risk Drug recall · FDA · Published December 10, 2019

Lupin Memantine Capsules Recall: Failed Dissolution Specifications

Lupin Pharmaceuticals recalls 28mg Memantine Hydrochloride Extended-release Capsules due to failed dissolution tests. Rx-only medication with specific NDC numbers and expiration dates.

🇺🇸 FDA recall #D-0629-2020DrugLupin Pharmaceuticals ›
Take action

Contact the company

Recalling firmLupin Pharmaceuticals Inc.Harborplace Tower, 111 S Calvert St Fl 21st · Baltimore, MD 21202-6174
✎ GovInfoNow plain-language explainer

Lupin Pharmaceuticals is recalling 28mg Memantine Hydrochloride Extended-release Capsules that failed dissolution tests during stability studies. This could affect medication effectiveness but does not pose an immediate safety risk to users. Read more at govinfonow.com/recall/37659-lupin-memantine-capsules-recall-failed-dissolution-specifications.

Source Summary by GovInfoNow · govinfonow.com/recall/37659-lupin-memantine-capsules-recall-failed-dissolution-specifications · Updated October 5, 2026 · FDA enforcement record: FDA #D-0629-2020

Cite this page

“Lupin Memantine Capsules Recall: Failed Dissolution Specifications.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37659-lupin-memantine-capsules-recall-failed-dissolution-specifications. Based on FDA recall #D-0629-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0629-2020%22&limit=1).

Lupin Pharmaceuticals Inc. recalled Memantine Hydrochloride Extended-release Capsules, 28mg, due to failed dissolution specifications, the FDA said on Dec. 10, 2019. The voluntary Class III recall affects 3,726 bottles distributed nationwide.

How to tell if you have it

  • Brand: Lupin Pharmaceuticals
  • Product: Memantine Hydrochloride Extended-release Capsules, 28mg
  • Packaging: 90-count bottles (NDC 68180-249-09) and 500-count bottles (NDC 68180-249-02)
  • Lot codes: H901787, H901788
  • Expiration date: March 2021

The hazard

The recall was initiated because high out-of-specification results were observed at stability studies for the capsules. The FDA classified this as a Class III recall.

Context

GovInfoNow's records show Lupin Pharmaceuticals Inc. has had 90 other recalls on record since Jan. 31, 2013. Other recent recalls of similar products include Lupin Clobetasol Cream Recall (Aug. 3, 2026), Lupin Glucagon Emergency Kit Recall (June 23, 2026), and Lupin prednisolone acetate ophthalmic suspension recall (June 4, 2026). Other recent recalls of similar products include Harvard Drug Group Memantine Capsules Recall (March 24, 2026), Sun Pharmaceutical Lisdexamfetamine Capsules Recall (Oct. 28, 2025), and Supernus Trokendi XR 50mg Capsules: Failed Dissolution Specifications Recall (Aug. 31, 2026).

How to tell if you have this one

Check for 28mg Memantine Hydrochloride Extended-release Capsules in 90-count bottles (NDC 68180-249-09) or 500-count bottles (NDC 68180-249-02). These were manufactured for specific lots with expiration dates up to March 2021.

  • Brand
    Lupin Pharmaceuticals
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Medication Details

    Verify the product's NDC number is 68180-249-09 or 68180-249-02 to confirm it's part of the recall.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 17 months after the firm started it.

1. Firm started the recall: Dec 10, 201912. FDA classified it Class III: Dec 23, 201923. Published in FDA’s Enforcement Report: Dec 25, 201934. FDA terminated the recall: Apr 29, 2021420192021
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Lupin Pharmaceuticals recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0629-2020 (December 10, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0629-2020 to see it in context.
  • Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA